Industry Funding Of Third-Party Technology Assessments Proposed By IMDMC
This article was originally published in The Gray Sheet
The Health Care Financing Administration should allow interested parties to fund an independent technology assessment of devices for which the agency is considering whether to cover under Medicare, the Indiana Medical Device Manufacturers Council said at HCFA's Sept. 25 "Town Hall" meeting in Baltimore.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.